373 related articles for article (PubMed ID: 22093958)
1. Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment.
Rix A; Lederle W; Siepmann M; Fokong S; Behrendt FF; Bzyl J; Grouls C; Kiessling F; Palmowski M
Eur J Radiol; 2012 Oct; 81(10):2710-6. PubMed ID: 22093958
[TBL] [Abstract][Full Text] [Related]
2. Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound.
Palmowski M; Lederle W; Gaetjens J; Socher M; Hauff P; Bzyl J; Semmler W; Günther RW; Kiessling F
Eur J Radiol; 2010 Jul; 75(1):e149-53. PubMed ID: 19945241
[TBL] [Abstract][Full Text] [Related]
3. Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment.
Palmowski M; Huppert J; Hauff P; Reinhardt M; Schreiner K; Socher MA; Hallscheidt P; Kauffmann GW; Semmler W; Kiessling F
Cancer Res; 2008 Sep; 68(17):7042-9. PubMed ID: 18757418
[TBL] [Abstract][Full Text] [Related]
4. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging.
Pysz MA; Foygel K; Panje CM; Needles A; Tian L; Willmann JK
Invest Radiol; 2011 Mar; 46(3):187-95. PubMed ID: 21150790
[TBL] [Abstract][Full Text] [Related]
5. Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects.
Baetke SC; Rix A; Tranquart F; Schneider R; Lammers T; Kiessling F; Lederle W
Radiology; 2016 Feb; 278(2):430-40. PubMed ID: 26313618
[TBL] [Abstract][Full Text] [Related]
6. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles.
Spivak I; Rix A; Schmitz G; Fokong S; Iranzo O; Lederle W; Kiessling F
Mol Imaging Biol; 2016 Apr; 18(2):180-90. PubMed ID: 26391990
[TBL] [Abstract][Full Text] [Related]
8. Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy.
Sorace AG; Saini R; Mahoney M; Hoyt K
J Ultrasound Med; 2012 Oct; 31(10):1543-50. PubMed ID: 23011617
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
[TBL] [Abstract][Full Text] [Related]
10. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
[TBL] [Abstract][Full Text] [Related]
11. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis.
Rychak JJ; Graba J; Cheung AM; Mystry BS; Lindner JR; Kerbel RS; Foster FS
Mol Imaging; 2007; 6(5):289-96. PubMed ID: 18092513
[TBL] [Abstract][Full Text] [Related]
12. A method for assessing the microvasculature in a murine tumor model using contrast-enhanced ultrasonography.
Loveless ME; Li X; Huamani J; Lyshchik A; Dawant B; Hallahan D; Gore JC; Yankeelov TE
J Ultrasound Med; 2008 Dec; 27(12):1699-709. PubMed ID: 19022995
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
Wang H; Hristov D; Qin J; Tian L; Willmann JK
Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
[TBL] [Abstract][Full Text] [Related]
14. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
[TBL] [Abstract][Full Text] [Related]
16. Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging.
Zwick S; Strecker R; Kiselev V; Gall P; Huppert J; Palmowski M; Lederle W; Woenne EC; Hengerer A; Taupitz M; Semmler W; Kiessling F
J Magn Reson Imaging; 2009 May; 29(5):1125-33. PubMed ID: 19388117
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging].
Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R
Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572
[TBL] [Abstract][Full Text] [Related]
18. Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.
Zhou J; Zhang H; Wang H; Lutz AM; El Kaffas A; Tian L; Hristov D; Willmann JK
Angiogenesis; 2017 Nov; 20(4):547-555. PubMed ID: 28721500
[TBL] [Abstract][Full Text] [Related]
19. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
